Filing Details
- Accession Number:
- 0001209191-15-060323
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-07-09 18:26:35
- Reporting Period:
- 2015-07-07
- Filing Date:
- 2015-07-09
- Accepted Time:
- 2015-07-09 18:26:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178879 | Amicus Therapeutics Inc | FOLD | Pharmaceutical Preparations (2834) | 200422823 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1613084 | Dipal Doshi | C/O Amicus Therapeutics 1 Cedar Brook Drive Cranbury NJ 08512 | Svp Strategy & Bus Dev | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-07-07 | 12,500 | $0.00 | 12,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-07-07 | 4,544 | $14.10 | 7,956 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2015-07-08 | 6,250 | $13.87 | 1,706 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted stock units | Acquisiton | 2015-07-07 | 12,500 | $0.00 | 12,500 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 12,500 | No | 4 | M | Direct |
Footnotes
- Restricted stock units convert into common stock on a one-for-one basis.
- The sales of shares of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 27, 2015.
- This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.74 to $14.00. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- On July 7, 2014, the reporting person was granted 25,000 restricted stock units, vesting in equal installments of 12,500 restricted stock units on July 7, 2015 and 12,500 restricted stock units on July 7, 2016.
Billionaire Hedge Funds
